Showing results (261-270 of 274) with videos related to
Sort By:
Pageof 28
Cell Reports|May 12, 2023
Sequencing of 19,219 exomes identifies a low-frequency variant in FKBP5 promoter predisposing to high myopia in a Han Chinese populationJianzhong Su, Jian Yuan, Liangde Xu, et al.Signal Transduction and Targeted Therapy|March 12, 2025
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II studyYing Yu, Yuxi Li, Rui Cui, et al.Clinical Lymphoma, Myeloma & Leukemia|April 6, 2023
Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS StudyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.Blood Advances|October 15, 2021
Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISHYuting Yan, Xiaoqi Qin, Jiahui Liu, et al.Blood|March 19, 2020
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myelomaYan Xu, Mariateresa Fulciniti, Mehmet K Samur, et al.Blood Advances|March 6, 2019
Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective studyXiao-Qi Qin, Gang An, Zeng-Jun Li, et al.Science Translational Medicine|November 19, 2025
Targeting the origins of multiple myeloma along hematopoietic stem cell lymphoid lineage differentiationJiaojiao Guo, Yaru Li, Zhiling Yan, et al.Cell Metabolism|December 19, 2023
Targeting gut microbial nitrogen recycling and cellular uptake of ammonium to improve bortezomib resistance in multiple myelomaYinghong Zhu, Xingxing Jian, Shuping Chen, et al.Cancer Research Communications|March 6, 2023
A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid NeoplasmsQiujin Shen, Yahui Feng, Xiaowen Gong, et al.Journal of Hematology & Oncology|July 14, 2025
Development and validation of a prognostic staging system for primary plasma cell leukemiaMengru Tian, Gang An, Weijun Fu, et al.Pageof 28